Journals / Acta Veterinaria Eurasia / 2021 / Cilt: 47 - Sayı: 2

Enhanced Significance of Laboratory Biosafety and Biosecurity During COVID-19 Pandemic

Pages
108–116
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article aims to explain biosafety andbiosecurity practices at BSL-3 laboratories, which are necessaryfor the studies of SARS-CoV-2 as the causative agent ofCOVID-19.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Seven coronavirus species, including severe acute respiratorysyndrome coronavirus 2 (SARS-CoV-2), cause respiratory diseasesin humans.
📊
Key Findings & Data:Four of these species, namely, HCoV 229E,HCoV NL63, HCoV HKU1, and HCoV OC43, typically cause mildupper respiratory infection in babies, kids, and the elderly.Severe acute respiratory syndrome coronavirus, Middle Eastrespiratory syndrome coronavirus, and SARS-CoV-2 lead tomore serious diseases in humans by infecting the lower respiratorytract.
💡
Conclusion & Impact:This article aims to explain biosafety andbiosecurity practices at BSL-3 laboratories, which are necessaryfor the studies of SARS-CoV-2 as the causative agent ofCOVID-19.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Seven coronavirus species, including severe acute respiratorysyndrome coronavirus 2 (SARS-CoV-2), cause respiratory diseasesin humans. Four of these species, namely, HCoV 229E,HCoV NL63, HCoV HKU1, and HCoV OC43, typically cause mildupper respiratory infection in babies, kids, and the elderly.Severe acute respiratory syndrome coronavirus, Middle Eastrespiratory syndrome coronavirus, and SARS-CoV-2 lead tomore serious diseases in humans by infecting the lower respiratorytract. Epidemic and pandemic situations are the consequencesof the rapid transmission of SARS-CoV-2 and largenumber of deaths. Evaluations related to the recent COVID-19pandemic have revealed some requirements, which are notwell known but essential for fighting against this disease. Theserequirements include the obligation to work at laboratorieswith high biosafety level (BSL) and conduction of studies underthe guidance of biosafety and biosecurity simultaneously.Likewise, to overcome the hazardous microorganisms, laboratoryresearch is required alongside therapeutic and diagnosticservices in the field. This article aims to explain biosafety andbiosecurity practices at BSL-3 laboratories, which are necessaryfor the studies of SARS-CoV-2 as the causative agent ofCOVID-19.

🔖

Cite This Article

KARAGÜL, M. S., SARAÇ, F., HASÖKSÜZ, M. (2021). Enhanced Significance of Laboratory Biosafety and Biosecurity During COVID-19 Pandemic. Acta Veterinaria Eurasia, Cilt: 47 - Sayı: 2, 108–116. https://ajindex.com/articles/353389

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Abacıoğlu, Y. H., & Sönmez, C. (2014). Ulusal Mikrobiyoloji Standartları Laboratuvar Güvenliği Rehberi. Türkiye Halk Sağlığı Kurumu, Sağlık Bakanlığı Yayın No: 937, Ankara. https://hastane.ksu.edu.tr/depo/ belgeler/Ulusal%20Mikrobiyoloji%20Standartlar%C4%B1.compressed_ 1710261701460340.pdf (Accessed on 25.10.2020)
  2. Ahmad, T., Haroon, Dhama, K., Sharun, K., Khan, F. M., Ahmed, I., Tiwari, R., Musa, T. H., Khan, M., Bonilla-Aldana, D. K., J Rodriguez-Morales, A., & Hui, J. (2020). Biosafety and biosecurity approaches to restrain/contain and counter SARS-CoV-2/COVID-19 pandemic: a rapid-review. Turkish Journal of Biology, 44(3), 132-145. [Crossref] Ahmad, T., & Hui, J. (2020). One health approach and coronavirus disease 2019. Human Vaccines & Immunotherapeutics, 16(4), 931-932. [Crossref] Astuto-Gribble, L. M., & Caskey, S. A. (2014). Laboratory Biosafety and Biosecurity Risk Assessment Technical Guidance Document. United States. doi:10.2172/1171429. https://www.osti. gov/biblio/1171429-laboratory-biosafety-biosecurity-risk-assessment- technical-guidance-document (Accessed on 25.10.2020) [Crossref] Buchan, B., Relich, R. F., & Mahlen, S. D. (2019). Interim Clinical Laboratory Guideline for Biological Safety the American Society for Microbiology. https://asm.org/ASM/media/Policy-and-Advocacy/Biosafety- white-paper-2019.pdf BVL, 2013. BVL-Federal Office of Consumer Protection and Food Safety, Bekanntmachung der Liste risikobewerteter Spender- und Empfängerorganismen für gentechnische Arbeiten BVL 112/2013/4 (Accessed on: 25.10.2020). http://www.bvl.bund.de/SharedDocs/ Downloads/06_Gentechnik/register_datenbanken/organismenliste_ pdf.pdf?__blob=publicationFile&v=7. Caskey, S., & Sevilla-Reyes, E. E. (2015).
  3. Risk assessment. In R. M. Salerno, J. Gaudioso (Eds.), Laboratory Biorisk Management, Biosafety and Biosecurity (pp.45-63).
  4. CRC Press, New York. [Crossref] CDC, (2009). Biosafety in Microbiological and Biomedical Laboratories. HHS Publication No. (CDC) 21-1112. https://www.cdc.gov/ labs/pdf/CDC-BiosafetyMicrobiologicalBiomedicalLaboratories- 2009-P.PDF (Accessed on 25.10.2020). CDC, (2019). Guidelines for Environmental Infection Control in Health- Care Facilities Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). https://www. cdc.gov/infectioncontrol/pdf/guidelines/environmental-guidelines- P.pdf (Accessed on 25.10.2020). CDC, (2020). Inspection Checklist forBSL-3 Laboratories (7 CFR 331; 9 CFR 121; 42 CFR 73; B